Miglitol use while Breastfeeding
Drugs containing Miglitol: Glyset
Miglitol Levels and Effects while Breastfeeding
Summary of Use during Lactation
Limited data indicate that miglitol is poorly excreted into breastmilk. It is unlikely to adversely affect the breastfed infant.
Drug Levels
Maternal Levels No published information was found as of the revision date. According to the manufacturer, 0.02% of a 100 mg oral dose or 0.2% of the weight-adjusted maternal dosage is excreted into breastmilk.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Acarbose, Chlorpropamide, Glyburide, Insulin, Metformin
References
Miglitol Identification
Substance Name
CAS Registry Number
72432-03-2
Drug Class
- Hypoglycemic Agents
Administrative Information
LactMed Record Number
407
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2010-12-07
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Miglitol use during Pregnancy
- Miglitol Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
